* denotes 2023 Innovation Award Winner
Human Brain Model of Opioid Addiction and Novel Therapeutics
Current state of the art technologies for CNS disease mechanism studies and drug discovery include rodent models. These models are failing in their predictive capacity in translational medicine applications. Our proprietary human neural organoid models yield clinically corroborated results of opioid use disorders and novel therapeutic drugs identified.